Mengyuan Jin
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
MerTK is Ectopically Expressed and Affects the Biological Function in Diffuse Large B-Cell Lymphoma.
MerTK is Ectopically Expressed and Affects the Biological Function in Diffuse Large B-Cell Lymphoma.
Journal: Hematological oncology
Published: September 26, 2023
Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma.
Journal: Hematological oncology
Published: May 06, 2022
Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway.
Journal: Bioengineered
Published: February 14, 2022
IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4.
Journal: Investigational new drugs
Published: December 23, 2021
The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma.
Journal: Hematological oncology
Published: December 19, 2021
Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma.
Journal: Translational oncology
Published: September 16, 2021
Feedback activation of NF-KB signaling leads to adaptive resistance to EZH2 inhibitors in prostate cancer cells.
Journal: Cancer cell international
Published: December 25, 2020
Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma.
Journal: Haematologica
Published: August 16, 2019
Recurrent PDGFRB mutations in unicentric Castleman disease.
Journal: Leukemia
Published: August 10, 2018
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.
Journal: Nature communications
Published: November 16, 2017
Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma.
Journal: British journal of haematology
Published: March 16, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026